Display options
Cite
Iankov ID, Kurokawa C, Viker K, et al. Live Attenuated Measles Virus Vaccine Expressing . Mol Ther Oncolytics. 2020;19:136-148doi: 10.1016/j.omto.2020.09.006.
Iankov, I. D., Kurokawa, C., Viker, K., Robinson, S. I., Ammayappan, A., Panagioti, E., Federspiel, M. J., & Galanis, E. (2020). Live Attenuated Measles Virus Vaccine Expressing . Molecular therapy oncolytics, 19136-148. https://doi.org/10.1016/j.omto.2020.09.006
Iankov, Ianko D, et al. "Live Attenuated Measles Virus Vaccine Expressing ." Molecular therapy oncolytics vol. 19 (2020): 136-148. doi: https://doi.org/10.1016/j.omto.2020.09.006
Iankov ID, Kurokawa C, Viker K, Robinson SI, Ammayappan A, Panagioti E, Federspiel MJ, Galanis E. Live Attenuated Measles Virus Vaccine Expressing . Mol Ther Oncolytics. 2020 Sep 23;19:136-148. doi: 10.1016/j.omto.2020.09.006. eCollection 2020 Dec 16. PMID: 33145397; PMCID: PMC7585873.
Copy Download .nbib Format: NLM
Share it on

Mol Ther Oncolytics. 2020 Sep 23;19:136-148. doi: 10.1016/j.omto.2020.09.006. eCollection 2020 Dec 16.

Live Attenuated Measles Virus Vaccine Expressing .

Molecular therapy oncolytics

Ianko D Iankov, Cheyne Kurokawa, Kimberly Viker, Steven I Robinson, Arun Ammayappan, Eleni Panagioti, Mark J Federspiel, Evanthia Galanis

Affiliations

  1. Department of Molecular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
  2. Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

PMID: 33145397 PMCID: PMC7585873 DOI: 10.1016/j.omto.2020.09.006

Abstract

Measles virus (MV) Edmonston derivative strains are attractive vector platforms in vaccine development and oncolytic virotherapy.

© 2020 The Author(s).

Keywords: Helicobacter pylori; heat-shock protein A; immune check point; immune response; measles virus; oncolytic agent; vaccine

References

  1. Annu Rev Immunol. 2001;19:523-63 - PubMed
  2. Blood. 2004 Mar 1;103(5):1641-6 - PubMed
  3. Clin Vaccine Immunol. 2008 Jul;15(7):1054-9 - PubMed
  4. Infect Immun. 1997 Feb;65(2):699-707 - PubMed
  5. World J Clin Cases. 2016 Jan 16;4(1):5-19 - PubMed
  6. J Immunol. 2015 Apr 15;194(8):3997-4007 - PubMed
  7. MMWR Morb Mortal Wkly Rep. 2019 Dec 06;68(48):1105-1111 - PubMed
  8. Vaccine. 2007 Apr 20;25(16):2974-83 - PubMed
  9. Mol Biol Rep. 2011 Jun;38(5):3173-80 - PubMed
  10. Cancer Gene Ther. 2014 Nov;21(11):483-90 - PubMed
  11. Clin Vaccine Immunol. 2017 Jan 5;24(1): - PubMed
  12. Gastroenterology. 2009 May;136(6):1863-73 - PubMed
  13. J Immunol. 2014 Aug 1;193(3):1233-45 - PubMed
  14. Virus Res. 2019 Apr 2;263:145-150 - PubMed
  15. EMBO J. 1995 Dec 1;14(23):5773-84 - PubMed
  16. Gene Ther. 2019 May;26(5):151-164 - PubMed
  17. J Intern Med. 2009 Apr;265(4):421-38 - PubMed
  18. Vaccine. 2013 Oct 1;31(42):4795-801 - PubMed
  19. J Biol Chem. 2008 May 30;283(22):15142-51 - PubMed
  20. Microbes Infect. 2003 Jul;5(8):705-13 - PubMed
  21. J Infect Dis. 2009 Oct 15;200(8):1311-7 - PubMed
  22. J Biol Inorg Chem. 2007 Aug;12(6):831-42 - PubMed
  23. Microb Pathog. 2009 Oct;47(4):231-6 - PubMed
  24. Sci Rep. 2016 Nov 21;6:37367 - PubMed
  25. J Virol. 1999 Nov;73(11):9568-75 - PubMed
  26. Mol Ther. 2009 Aug;17(8):1395-403 - PubMed
  27. Helicobacter. 2008 Jun;13(3):191-9 - PubMed
  28. Mol Ther. 2012 Jun;20(6):1139-47 - PubMed
  29. Curr Microbiol. 2011 Sep;63(3):239-49 - PubMed
  30. J Cell Physiol. 2008 Jul;216(1):78-82 - PubMed
  31. J Immunol. 2018 Jul 1;201(1):264-277 - PubMed
  32. J Virol. 1998 Feb;72(2):891-9 - PubMed
  33. J Virol. 1998 Sep;72(9):7420-7 - PubMed
  34. Expert Opin Biol Ther. 2013 Apr;13(4):483-502 - PubMed
  35. Clin Microbiol Rev. 2006 Jul;19(3):449-90 - PubMed
  36. Mol Ther. 2007 Mar;15(3):588-97 - PubMed
  37. Expert Opin Biol Ther. 2017 Mar;17(3):353-363 - PubMed
  38. J Microbiol. 2010 Apr;48(2):223-8 - PubMed
  39. J Natl Cancer Inst. 2018 Oct 1;110(10):1123-1132 - PubMed
  40. Mol Ther. 2007 Jan;15(1):114-22 - PubMed
  41. Expert Rev Vaccines. 2019 Apr;18(4):393-403 - PubMed
  42. PLoS One. 2015 Jun 23;10(6):e0130391 - PubMed
  43. Vaccine. 2011 Feb 11;29(8):1710-20 - PubMed
  44. Cancer Res. 2015 Jan 1;75(1):22-30 - PubMed
  45. Sci Rep. 2017 Dec 4;7(1):16892 - PubMed
  46. J Virol. 2007 Dec;81(23):12859-71 - PubMed
  47. Vaccine. 2009 Feb 5;27(6):846-52 - PubMed
  48. Virology. 2007 Mar 30;360(1):72-83 - PubMed
  49. Prostate. 2009 Jan 1;69(1):82-91 - PubMed
  50. Curr Cancer Drug Targets. 2018;18(2):177-187 - PubMed
  51. J Biol Chem. 2019 Feb 8;294(6):2109-2120 - PubMed
  52. Breast Cancer Res Treat. 2010 Aug;122(3):745-54 - PubMed
  53. Infect Genet Evol. 2017 Apr;49:309-317 - PubMed
  54. J Virol. 2019 Jan 17;93(3): - PubMed
  55. Microbiology (Reading). 1997 Jan;143 ( Pt 1):45-53 - PubMed
  56. Oncoimmunology. 2017 Jan 31;6(4):e1285992 - PubMed
  57. Nat Rev Cancer. 2019 Mar;19(3):133-150 - PubMed
  58. Mol Ther Oncolytics. 2018 Dec 31;12:147-161 - PubMed
  59. Cancer Gene Ther. 2013 Nov;20(11):630-7 - PubMed
  60. Stem Cell Res Ther. 2015 Mar 26;6:48 - PubMed
  61. J Bacteriol. 2010 Mar;192(5):1231-7 - PubMed

Publication Types

Grant support